Lifetime Methamphetamine Use Disorder and Reported Sleep Quality in Adults Living with HIV.
Adult
Amphetamine-Related Disorders
/ complications
Anti-HIV Agents
/ therapeutic use
Cognitive Dysfunction
/ complications
Female
HIV Infections
/ complications
HIV Seronegativity
Humans
Male
Methamphetamine
/ administration & dosage
Middle Aged
Neuropsychological Tests
Self Report
Sleep
Sleep Wake Disorders
/ complications
AIDS
Depression
Stimulant
Substance use
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
pubmed:
11
4
2020
medline:
30
9
2020
entrez:
11
4
2020
Statut:
ppublish
Résumé
This study evaluated whether a history of lifetime methamphetamine (MA) use disorder increases risk for poor sleep quality in people with or without HIV infection (HIV+/HIV-). Participants (n = 313) were stratified into four groups based on HIV status and lifetime MA use disorder diagnosis [HIV+/MA+ (n = 84); HIV+/MA- (n = 141); HIV-/MA+ (n = 16); and HIV-/MA- (n = 72)] and compared on global sleep outcomes using the Pittsburgh Sleep Quality Index (PSQI). Significant differences on global sleep were observed between HIV+/MA+ and HIV+/MA- groups, but not between the HIV- groups. Follow-up multiple regression analyses within the HIV+ subgroups examined global sleep scores as a function of MA status and clinical covariates, including those related to HIV disease and demographics. HIV+ individuals with a history of MA use disorder evidenced significantly poorer sleep quality and were more likely to be classified as problematic sleepers than those without a lifetime disorder. This was independent of depressed mood, body mass index, and viral suppression while on treatment. Poorer reported sleep quality among HIV+/MA+ was associated also with multiple adverse functional outcomes, including greater objective cognitive impairment, unemployment, clinical ratings of functional impairment, and self-reported cognitive difficulties, decreased independence in activities of daily living, and poorer overall life quality. Interventions to avoid or curtail MA use in HIV+ individuals may help protect sleep quality and improve functioning.
Identifiants
pubmed: 32274672
doi: 10.1007/s10461-020-02857-7
pii: 10.1007/s10461-020-02857-7
pmc: PMC7508964
mid: NIHMS1583634
doi:
Substances chimiques
Anti-HIV Agents
0
Methamphetamine
44RAL3456C
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3071-3082Subventions
Organisme : NIDA NIH HHS
ID : P50 DA026306
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA031098
Pays : United States
Organisme : NIDA NIH HHS
ID : F31 AG064989
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH062512
Pays : United States
Organisme : NIA NIH HHS
ID : F31 AG064989
Pays : United States
Références
Clark JP III, Sampair CS, Kofuji P, Nath A, Ding JM. HIV protein, transactivator of transcription, alters circadian rhythms through the light entrainment pathway. Am J Physiol Regul Integr Comp Physiol. 2005;289(3):R656–R662662.
pubmed: 15860648
Wu J, Wu H, Lu C, Guo L, Li P. Self-reported sleep disturbances in HIV-infected people: a meta-analysis of prevalence and moderators. Sleep Med. 2015;16(8):901–7.
pubmed: 26188954
Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97–111.
pubmed: 12531146
Pellowski JA, Kalichman SC, Matthews KA, Adler N. A pandemic of the poor: social disadvantage and the U.S. HIV epidemic. Am Psychol. 2013;68(4):197–209.
pubmed: 23688088
pmcid: 3700367
Semple SJ, Patterson TL, Temoshok LR, McCutchan JA, Straits-Troster KA, Chandler JL, et al. Identification of psychobiological stressors among HIV-positive women. HIV Neurobehavioral Research Center (HNRC) Group. Women Health. 1993;20(4):15–36.
pubmed: 8171874
Rondanelli M, Solerte SB, Fioravanti M, Scevola D, Locatelli M, Minoli L, et al. Circadian secretory pattern of growth hormone, insulin-like growth factor type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone, and prolactin during HIV infection. AIDS Res Hum Retroviruses. 1997;13(14):1243–9.
pubmed: 9310292
Allavena C, Guimard T, Billaud E, De la Tullaye S, Reliquet V, Pineau S, et al. Prevalence and risk factors of sleep disturbance in a large hiv-infected adult population. Aids Behav. 2016;20(2):339–44.
pubmed: 26271816
Passaro RC, Pandhare J, Qian HZ, Dash C. The complex interaction between methamphetamine abuse and HIV-1 pathogenesis. J Neuroimmune Pharmacol. 2015;10(3):477–86.
pubmed: 25850893
pmcid: 4779551
Bateganya M, Colfax G, Shafer LA, Kityo C, Mugyenyi P, Serwadda D, et al. Antiretroviral therapy and sexual behavior: a comparative study between antiretroviral-naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala. Uganda Aids Patient Care St. 2005;19(11):760–8.
Passaro RC, Ramsey K, Segura ER, Lake JE, Reback CJ, Clark JL, et al. Speed kills: associations between methamphetamine use, HIV infection, tobacco use, and accelerated mortality among gay and bisexual men in Los Angeles, CA 20years after methamphetamine dependence treatment. Drug Alcohol Depen. 2019;195:164–9.
Wang X, Ho WZ. Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission. Life Sci. 2011;88(21–22):972–9.
pubmed: 21056582
Carrico AW, Flentje A, Kober K, Lee S, Hunt P, Riley ED, et al. Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection. Brain Behav Immun. 2018;71:108–15.
pubmed: 29679637
pmcid: 6003871
Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I, et al. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis. 2003;188(12):1820–6.
pubmed: 14673760
Fairbairn N, Kerr T, Milloy MJ, Zhang R, Montaner J, Wood E. Crystal methamphetamine injection predicts slower HIV RNA suppression among injection drug users. Addict Behav. 2011;36(7):762–3.
pubmed: 21396784
pmcid: 3081981
Blackstone K, Iudicello JE, Morgan EE, Weber E, Moore DJ, Franklin DR, et al. Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use. J Addict Med. 2013;7(4):255–63.
pubmed: 23648641
pmcid: 3737384
Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, et al. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc. 2004;10(1):1–14.
pubmed: 14751002
Chang L, Ernst T, Speck O, Grob CS. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry. 2005;162(2):361–9.
pubmed: 15677602
pmcid: 4899042
Semple SJ, Patterson TL, Grant I. Motivations associated with methamphetamine use among HIV+ men who have sex with men. J Subst Abuse Treat. 2002;22(3):149–56.
pubmed: 12039618
Kish SJ. Pharmacologic mechanisms of crystal meth. CMAJ. 2008;178(13):1679–82.
pubmed: 18559805
pmcid: 2413312
London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, et al. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry. 2005;58(10):770–8.
pubmed: 16095568
London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry. 2004;61(1):73–84.
pubmed: 14706946
Perez AY, Kirkpatrick MG, Gunderson EW, Marrone G, Silver R, Foltin RW, et al. Residual effects of intranasal methamphetamine on sleep, mood, and performance. Drug Alcohol Depend. 2008;94(1–3):258–62.
pubmed: 18078723
Mahoney JJ III, De La Garza R, Jackson BJ II, Verrico CD, Ho A, Iqbal T, et al. The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders. Psychiatry Res. 2014;219(2):367–71.
pubmed: 24951161
pmcid: 4119803
Tang J, Liao Y, He H, Deng Q, Zhang G, Qi C, et al. Sleeping problems in Chinese illicit drug dependent subjects. BMC Psychiatry. 2015;15:28.
pubmed: 25884573
pmcid: 4337091
Lago JA, Kosten TR. Stimulant withdrawal. Addiction. 1994;89(11):1477–81.
pubmed: 7841859
Baberg HT, Nelesen RA, Dimsdale JE. Amphetamine use: return of an old scourge in a consultation psychiatry setting. Am J Psychiatry. 1996;153(6):789–93.
pubmed: 8633691
Reback CJ, Larkins S, Shoptaw S. Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. Aids Care. 2003;15(6):775–85.
pubmed: 14617499
World Health Organization. Composite diagnositic international interview (CIDI, version 2.1). Geneva: World Health Organization; 1998.
Beck A, Steer R, Brown G. Manual for beck depression inventory II (BDI-II). San Antonio: Psychology Corporation; 1996.
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–21313.
pubmed: 2748771
Rubinstein ML, Selwyn PA. High prevalence of insomnia in an outpatient population with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19(3):260–5.
pubmed: 9803968
Putnins SI, Griffin ML, Fitzmaurice GM, Dodd DR, Weiss RD. Poor sleep at baseline predicts worse mood outcomes in patients with co-occurring bipolar disorder and substance dependence. J Clin Psychiatry. 2012;73(5):703–8.
pubmed: 22313797
pmcid: 3349805
Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010;75(23):2087–96.
pubmed: 21135382
pmcid: 2995535
Heaton RK, Miller SW, Taylor MJ, Grant I. Revised comprehensive norms for an expanded halstead reitan battery: demographically adjusted neuropsychological norms for African American and caucasian adults. Lutz: Psychological Assessment Resources, Inc; 2004.
Heaton RK, Taylor MJ, Manly J. Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. Clinical interpretation of the WAIS-III and WMS-III. San Diego: Academic Press; 2003. p. 181–210.
Norman MA, Moore DJ, Taylor M, Franklin D Jr, Cysique L, Ake C, et al. Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version. J Clin Exp Neuropsychol. 2011;33(7):793–804.
pubmed: 21547817
pmcid: 3154384
Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, et al. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol. 2012;26(6):894–908.
pubmed: 22708483
Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10(3):317–31.
pubmed: 15147590
Woods SP, Iudicello JE, Moran LM, Carey CL, Dawson MS, Grant I. HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology. 2008;22(1):110–7.
pubmed: 18211160
pmcid: 2249562
Chelune GJ, Heaton RK, Lehman RAW. Neuropsychological and personality correlates of patients' complaints of disability. Advances in clinical neuropsychology, vol 3. New York: Plenum Press; 1986. p. 95–126.
Crooks V, Waller S, Smith T, Hahn TJ. The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol. 1991;46(4):M139–M144144.
pubmed: 2071835
Farivar SS, Cunningham WE, Hays RD. Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.I. Health Qual Life Outcomes. 2007;5:54.
pubmed: 17825096
pmcid: 2065865
Dustin DT, Kawachi I, Redline S. The social epidemiology of sleep. New York: Oxford University Press; 2019.
Millar BM, Goedel WC, Duncan DT. Sleep health among sexual and gender minorities. Soc Epidemiol Sleep. 2019:187.
Colfax G, Shoptaw S. The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep. 2005;2(4):194–9.
pubmed: 16343378
Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, et al. Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med. 1994;56(1):8–17.
pubmed: 8197319
Woods SP, Weber E, Weisz BM, Twamley EW, Grant I, Group HIVNRP. Prospective memory deficits are associated with unemployment in persons living with HIV infection. Rehabil Psychol. 2011;56(1):77–84.
pubmed: 21401289
pmcid: 3264430
Bhatia MS, Munjal S. Prevalence of depression in people living with HIV/aids undergoing art and factors associated with it. J Clin Diagn Res. 2014;8(10):1–4.
Adinoff B. Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry. 2004;12(6):305–20.
pubmed: 15764467
pmcid: 1920543
Jiao D, Liu Y, Li X, Liu J, Zhao M. The role of the GABA system in amphetamine-type stimulant use disorders. Front Cell Neurosci. 2015;9:162.
pubmed: 25999814
pmcid: 4419710
Padgett CL, Lalive AL, Tan KR, Terunuma M, Munoz MB, Pangalos MN, et al. Methamphetamine-evoked depression of GABA(B) receptor signaling in GABA neurons of the VTA. Neuron. 2012;73(5):978–89.
pubmed: 22405207
pmcid: 3560416
Kamata K, Kameyama T. Effect of chronic administration of methamphetamine on the responsiveness of substantia nigra zona reticulata neurons to GABA or a GABA agonist in rats. Naunyn Schmiedebergs Arch Pharmacol. 1986;334(4):458–62.
pubmed: 3821936
Blumenfeld H. Neuroanatomy through clinical cases. 2nd ed. Sunderland: Sinauer Associates Inc.; 2012.
Association AP. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Publication; 2013.
Downing MJ Jr, Houang ST, Scheinmann R, Yoon IS, Chiasson MA, Hirshfield S. Engagement in care, psychological distress, and resilience are associated with sleep quality among HIV-positive gay, bisexual, and other men who have sex with men. Sleep Health. 2016;2(4):322–9.
pubmed: 28191491
pmcid: 5300085
White JL, Darko DF, Brown SJ, Miller JC, Hayduk R, Kelly T, et al. Early central nervous system response to HIV infection: sleep distortion and cognitive-motor decrements. AIDS. 1995;9(9):1043–50.
pubmed: 8527076
Norman SE, Chediak AD, Freeman C, Kiel M, Mendez A, Duncan R, et al. Sleep disturbances in men with asymptomatic human immunodeficiency (HIV) infection. Sleep. 1992;15(2):150–5.
pubmed: 1579789
Norman SE, Chediak AD, Kiel M, Cohn MA. Sleep disturbances in HIV-infected homosexual men. AIDS. 1990;4(8):775–81.
pubmed: 2261133
Wiegand M, Moller AA, Schreiber W, Krieg JC, Fuchs D, Wachter H, et al. Nocturnal sleep EEG in patients with HIV infection. Eur Arch Psychiatry Clin Neurosci. 1991;240(3):153–8.
pubmed: 1827600
Ferini-Strambi L, Oldani A, Tirloni G, Zucconi M, Castagna A, Lazzarin A, et al. Slow wave sleep and cyclic alternating pattern (CAP) in HIV-infected asymptomatic men. Sleep. 1995;18(6):446–50.
pubmed: 7481416
Jean-Louis G, Weber KM, Aouizerat BE, Levine AM, Maki PM, Liu C, et al. Insomnia symptoms and HIV infection among participants in the Women's Interagency HIV Study. Sleep. 2012;35(1):131–7.
pubmed: 22215927
pmcid: 3242680
Lee KA, Gay C, Portillo CJ, Coggins T, Davis H, Pullinger CR, et al. Symptom experience in HIV-infected adults: a function of demographic and clinical characteristics. J Pain Sympt Manag. 2009;38(6):882–93.
Weissman MM, Greenwald S, Niño-Murcia G, Dement WC. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry. 1997;19(4):245–50.
pubmed: 9327253
Thomsen DK, Mehlsen MY, Christensen S, Zachariae R. Rumination—relationship with negative mood and sleep quality. Personality Individ Differ. 2003;34(7):1293–301.
Heitkemper M, Jarrett M, Burr R, Cain K, Landis C, Lentz M, et al. Subjective and objective sleep indices in women with irritable bowel syndrome. Neurogastroenterol Motil. 2005;17(4):523–30.
pubmed: 16078941
Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res. 2002;53(3):737–40.
pubmed: 12217446
Gutierrez J, Tedaldi EM, Armon C, Patel V, Hart R, Buchacz K. Sleep disturbances in HIV-infected patients associated with depression and high risk of obstructive sleep apnea. SAGE Open Med. 2019;7:2050312119842268.
pubmed: 31001423
pmcid: 6454647
Palmer CA, Alfano CA. Sleep and emotion regulation: an organizing, integrative review. Sleep Med Rev. 2017;31:6–16.
pubmed: 26899742
Lim AS, Kowgier M, Yu L, Buchman AS, Bennett DA. Sleep fragmentation and the risk of incident Alzheimer's disease and cognitive decline in older persons. Sleep. 2013;36(7):1027–32.
pubmed: 23814339
pmcid: 3669060
O'Brien EM, Mindell JA. Sleep and risk-taking behavior in adolescents. Behav Sleep Med. 2005;3(3):113–33.
pubmed: 15984914